Prostate cancer treatment - China's perspective

Cancer Lett. 2022 Dec 1:550:215927. doi: 10.1016/j.canlet.2022.215927. Epub 2022 Sep 24.

Abstract

Prostate cancer (PCa) incidence and mortality have rapidly increased in China. Notably, unique epidemiological characteristics of PCa are found in the Chinese PCa population, including a low but rising incidence and an inferior but improving disease prognosis. Consequently, the current treatment landscape of PCa in China demonstrates distinct features. Establishing a more thorough understanding of the characteristics of Chinese patients may help provide novel insights into potential treatment strategies for PCa patients. Herein, we review the epidemiological status and differences in treatment modalities of Chinese PCa patients. In addition, we discuss the underlying socioeconomic and biological factors that contribute to such diversity and further propose directions for future efforts in optimizing the PCa treatment in China.

Keywords: Active surveillance; Prostate cancer; Radiation therapy; Radical prostatectomy; Traditional Chinese medicine.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • China / epidemiology
  • Humans
  • Male
  • Prognosis
  • Prostatic Neoplasms* / epidemiology
  • Prostatic Neoplasms* / therapy